CreaGen is located in Woburn, MA, just 8 miles (15 minutes) north of Cambridge, Massachusetts, and the hub of the most robust life sciences cluster in the world. Massachusetts is the home to over 500 pharmaceutical and biotechnology companies along with world-renowned academic research institutions.
CreaGen is a premier chemistry-based drug discovery/medicinal chemistry contract research firm with extensive experience in synthetic organic chemistry, bio-conjugation chemistry, lead generation, lead optimization, natural products scaffolds, building block synthesis, custom library development, structure and fragment based drug design, and HTP parallel synthesis and purification.
Our approach to contract and discovery chemistry has been refined over 16 years of close collaborations with academic researchers, emerging companies, established biotechs, and multinational pharmaceutical organizations. Our flexible business model allows the ability to provide FTE-based, Project-based or offer shared risk opportunities with our clients. In the corporate sectors CreaGen has established close collaborations with AstraZeneca, Abbvie, RepliGen, Medimmune, Microbiotix and others. In the academic sector, CreaGen has collaborated with the Harvard Medical School, Dana Farber Cancer Institute, MGH, Joslin Diabetes Center, NCATS, NIDDK and others. Unlike most chemistry service providers, CreaGen conveys a true ‘partnership approach’ to our client’s
Our scientists are creative and highly skilled with extensive experience in a broad range of therapeutic areas and skills. With over 100 years of combined drug discovery and medicinal chemistry expertise, CreaGen scientists offer our partners an excellent and unmatched opportunity to expand their core business on a fast track while significantly reducing overhead costs.